Elevated plasma transforming growth factor-β1 levels in breast cancer patients decrease after surgical removal of the tumor

Annals of Surgery

Volumn 222, Issue 2, 1995, Pages 155-162

  Kong, F M ^a   Anscher, M S ^a   Murase, T ^a   Abbott, B D ^a   Iglehart, J D ^a   Jirtle, R L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; ARTICLE; BREAST CANCER; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL;

EID: 0029133133     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199508000-00007     Document Type: Article

References (0)